Author: Contec Healthcare
Tags:Compounding Pharmacy, USP, Webinar

From Mortar to Mask: Navigating USP <795>, <800> & NAPRA Model Standards in Nonsterile Compounding

The Contec Healthcare webinar is an educational session intended to support practitioners navigating the complexities of hazardous drug nonsterile compounding while adhering to USP <795>, <800> and NAPRA Model standards.
00:0300:05

Webinar Description

 

This webinar is designed for pharmacy professionals who perform nonsterile compounding in community or hospital settings, whether working with hormones, hazardous drugs (HDs), or non-hazardous preparations. If you compound, this webinar applies to you.
 
We will explore how the latest standards, including USP <795> and USP <800>, along with parallels to NAPRA Model Standards, are reshaping expectations for compounder safety, quality, and operational practices in nonsterile compounding environments.


 
Participants will gain practical insight into:

 

  • Why these standards apply beyond sterile and hospital-only settings

     

  • How non-compliance can impact operator safety, patient safety, and business continuity

     

  • The occupational hazards associated with hormones and other nonsterile compounds

     

  • How to prevent cross-contamination and protect staff through improved practices

     

  • Real-world strategies, resources, and products that are helping pharmacies meet today’s requirements

 

This session will also feature field experiences and grassroots insights from the front lines of nonsterile compounding, along with practical tools to support implementation.

 

Key Takeaways

  • Hazardous drug nonsterile compounding is a highly specialized practice area.
  • USP <795>, USP <800>, and NAPRA standards guide safe practice.
  • Occupational exposure prevention is a primary concern.
  • Compliance supports both patient safety and worker protection.
  • Facility design and containment strategies are critical.
  • Ongoing education and competency assessment are essential for success.

Webinar Section Summaries

Overview of Nonsterile Hazardous Drug Compounding

Nonsterile HD compounding involves unique risks compared to traditional nonsterile practices.

 

Key points include:

 

  • Increased occupational exposure risks
  • Need for specialized equipment and workflows
  • Greater emphasis on containment and safety

 

The session frames HD compounding as a specialized practice area requiring heightened awareness.

 

Applicable Standards: USP <795>, USP <800>, and NAPRA

 

The webinar reviews the key standards governing practice:

 

  • USP <795> → Nonsterile compounding standards
  • USP <800> → Hazardous drug handling requirements
  • NAPRA Model Standards → Canadian guidance and expectations

 

The discussion highlights the overlap between these standards and the importance of understanding regional requirements.

 

Importance of Compliance and Patient Safety

 

Compliance is presented as essential for:

 

  • Protecting personnel
  • Ensuring patient safety
  • Delivering high-quality compounded preparations

 

The presenter reinforces that standards exist to reduce risk and improve consistency in practice.

 

Protecting Personnel from Hazardous Drug Exposure

A major focus is preventing occupational exposure to hazardous drugs.

 

Risks include:

 

  • Contact exposure
  • Inhalation of powders or aerosols
  • Environmental contamination

 

Protecting workers requires layered safety controls and proper procedures.

 

Facility Design and Environmental Considerations

The webinar acknowledges that the studio environment resembles a sterile cleanroom, while the focus remains nonsterile compounding.

 

Key environmental considerations include:

 

  • Proper containment equipment
  • Workflow separation
  • Surface and environmental control

 

Facilities must be designed to minimize contamination and exposure.

 

Training, Education, and Competency Development

 

The presenter repeatedly emphasizes the importance of:

 

  • Comprehensive training
  • Competency assessment
  • Ongoing education

 

Hazardous drug compounding cannot be safely implemented without strong knowledge and preparation.

 

Challenges and Best Practices in Nonsterile HD Compounding

 

The session concludes by reinforcing best practices such as:

 

  • Following regulatory standards
  • Using appropriate equipment
  • Maintaining contamination control procedures
  • Building strong training programs

 

Safe and compliant practice requires continuous improvement and vigilance.

 

More from Studio 289

Behind the Scenes